Lucid Diagnostics Inc. (LUCD)
USD 0.79
(-2.05%)
USD 0.79
(-2.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -32.81 Million | -29.68 Million | -17.66 Million | -5.62 Million | -2.36 Million | -113.7 Thousand |
| Net Income | -52.66 Million | -56.17 Million | -28.07 Million | -8.27 Million | -4.42 Million | -1.12 Million |
| Depreciation & Amortization | 2.49 Million | 1.93 Million | 4000.00 | - | - | - |
| Deferred income taxes | -5.76 Billion | - | -10.47 Million | - | - | - |
| Stock-based compensation | 6.82 Million | 14.99 Million | 9.59 Million | 65 Thousand | 173.94 Thousand | 79.85 Thousand |
| Change in working capital | 5.67 Million | 8.9 Million | 807 Thousand | 2.58 Million | 1.88 Million | 720.05 Thousand |
| Other non-cash items | 5.77 Billion | 653 Thousand | 10.47 Million | -1.08 Million | -127.9 Thousand | -205.06 Thousand |
| Investing Cash Flow | -221 Thousand | -4.1 Million | -862 Thousand | - | - | - |
| Investments in PPE | -221 Thousand | -908 Thousand | -862 Thousand | - | - | - |
| Acquisitions | - | -3.2 Million | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -221 Million | -3.2 Million | -862 Million | - | - | - |
| Financing Cash Flow | 29.46 Million | 2.61 Million | 72.07 Million | 5.58 Million | 2.5 Million | 131.5 Thousand |
| Debt repayment | -10 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 551 Million | 109 Million | - | - | - | - |
| Common Stock Issuance | 29.46 Million | 2.61 Million | 70 Million | 5.58 Million | 2.5 Million | 131.5 Thousand |
| Other Financing Activities | 10.28 Billion | 2.61 Million | 2.07 Million | 5.57 Million | 2.5 Million | 197.25 Thousand |
| Accounts receivables | -28 Thousand | 183 Thousand | -200 Thousand | - | - | - |
| Accounts payables | 89 Thousand | -445 Thousand | -665 Thousand | 1.14 Million | 301.85 Thousand | 497.22 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 5.61 Million | 9.16 Million | 1.67 Million | 1.43 Million | 1.58 Million | 222.82 Thousand |
| Cash at beginning of period | 22.47 Million | 53.65 Million | 111 Thousand | 156.4 Thousand | 17.8 Thousand | - |
| Cash at end of period | 18.89 Million | 22.47 Million | 53.65 Million | 111.25 Thousand | 156.4 Thousand | 17.8 Thousand |
| Capital Expenditure | -221 Thousand | -908 Thousand | -862 Thousand | - | - | - |
| Effect of forex changes on cash | -3.57 Billion | - | - | - | - | - |
| Net cash flow / Change in cash | -3.57 Million | -31.18 Million | 53.54 Million | -45.14 Thousand | 138.6 Thousand | 17.8 Thousand |
| Free Cash Flow | -33.03 Million | -30.59 Million | -18.53 Million | -5.62 Million | -2.36 Million | -113.7 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11 Million | -10.61 Million | -52.66 Million | -10.83 Million | -14.2 Million | -11.38 Million |
| Depreciation & Amortization | 229 Thousand | 501 Thousand | 2.49 Million | 629 Thousand | 625 Thousand | 633 Thousand |
| Deferred income taxes | - | - | -5.76 Billion | -2.09 Million | 4.15 Million | -1.47 Million |
| Stock-based compensation | 1.2 Million | 932 Thousand | 6.82 Million | 963 Thousand | 1.25 Million | 1.39 Million |
| Change in working capital | -1.91 Million | -3.33 Million | 5.67 Million | -201 Thousand | 503 Thousand | 2.67 Million |
| Other non-cash items | 1.84 Million | 2.01 Million | 5.77 Billion | 1.55 Million | -1.11 Million | 1.13 Million |
| Investing Cash Flow | - | -37 Thousand | -221 Thousand | -175 Thousand | -14 Thousand | -15 Thousand |
| Investments in PPE | - | -37 Thousand | -221 Thousand | -175 Thousand | -14 Thousand | -15 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -37 Million | -221 Million | -221 Million | - | - |
| Financing Cash Flow | 11.63 Million | 18.52 Million | 29.46 Million | 5 Million | 275 Thousand | 75 Thousand |
| Debt repayment | - | - | -10 Million | -10 Million | - | -75 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | 353 Million | 551 Million | 275 Million | - | - |
| Common Stock Issuance | 11.63 Million | 18.52 Million | 29.46 Million | 5 Million | 275 Thousand | 75 Thousand |
| Other Financing Activities | - | 4 Million | 10.28 Billion | 10.54 Billion | - | 75 Thousand |
| Accounts receivables | -111 Thousand | -4000.00 | -28 Thousand | -24 Thousand | 14 Thousand | -8000.00 |
| Accounts payables | -67 Thousand | -176 Thousand | 89 Thousand | 151 Thousand | 357 Thousand | 12 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.73 Million | -3.15 Million | 5.61 Million | -328 Thousand | 132 Thousand | 2.67 Million |
| Cash at beginning of period | 24.76 Million | 18.89 Million | 22.47 Million | 24.05 Million | 32.57 Million | 39.52 Million |
| Cash at end of period | 24.92 Million | 24.76 Million | 18.89 Million | 18.89 Million | 24.05 Million | 32.57 Million |
| Capital Expenditure | - | -37 Thousand | -221 Thousand | -175 Thousand | -14 Thousand | -15 Thousand |
| Effect of forex changes on cash | - | - | -3.57 Billion | -2.66 Billion | 1.26 Billion | 1.4 Billion |
| Net cash flow / Change in cash | 151 Thousand | 5.87 Million | -3.57 Million | -5.15 Million | -8.52 Million | -6.95 Million |
| Free Cash Flow | -11.48 Million | -12.64 Million | -33.03 Million | -10.15 Million | -8.79 Million | -7.02 Million |
000685
STG
SVIK
SUS
MRMD
MTO